The efficacy of lowering HbAlc with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial

Category Primary study
JournalDiabetologia
Year 2009
This article has no abstract
Epistemonikos ID: 26f02994d6a177f2d04b6dc700ff47707b77d258
First added on: Jul 31, 2018